Troriluzole HCl

Troriluzole hydrochloride is a third-generation peptide precursor of Riluzole (HY-B0211) and is an orally active glutamate modulator. Troriluzole hydrochloride can reduce synaptic glutamate levels and enhance the uptake of synaptic glutamate. Troriluzole hydrochloride shows potential for treating Alzheimer's disease and Generalized Anxiety Disorder (GAD) .


Cat. No.: EX-A17508A	Purity: >98%

	Chemical structure of Troriluzole HCl

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
25mg	477	in_stock
50mg	759	in_stock
100mg	1229	in_stock
250mg	2455	in_stock
500mg	3920	in_stock
1g	6319	in_stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


CAS No.	1926204-76-3
Purity	>98%
Formula	C15H17ClF3N5O4S
Mol Weight	455.84

Reference:	[1].Schanzer B, et al. Novel investigational therapeutics for generalized anxiety disorder (GAD). Expert Opin Investig Drugs. 2019 Nov;28(11):1003-1012. [2].Huang LK, et al. Clinical trials of new drugs for Alzheimer disease. J Biomed Sci. 2020 Jan 6;27(1):18.
CoA	CoA of Troriluzole HCl

Smiles:	O=C(CN(C)C(CNC(CN)=O)=O)NC1=NC2=CC=C(OC(F)(F)F)C=C2S1.Cl


		Search